| Sources | Names Used |
|---|---|
| CTRPv2 | Repligen 136 |
| PharmacoGx | Repligen 136 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WDR59 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | SNX24 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | LYSMD4 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | CT45A2 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | TTPAL | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | USP44 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | VHL | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | LRIG3 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | DCHS1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | MGAT2 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
